| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.3M | +150.7% |
| SG&A Expense | $8.6M | +64.9% |
| Operating Income | -$14.9M | -92.9% |
| Income Tax | $30 | -98.2% |
| Net Income | -$14.3M | -85.7% |
| EPS (Basic) | -$1.73 | +8.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.6M | -75.4% |
| Short-term Investments | $16.8M | — |
| Current Assets | $27.2M | -32.5% |
| Total Assets | $28.1M | -30.8% |
| Current Liabilities | $3.4M | -25.4% |
| Total Liabilities | $3.4M | -26.6% |
| Stockholders' Equity | $24.6M | -31.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.1M | -15.8% |
| Capital Expenditures | $4K | +0.0% |
| Investing Cash Flow | -$16.4M | -3768.8% |
| Financing Cash Flow | $48.3M | +0.0% |
| Free Cash Flow | -$13.1M | -15.8% |